alpha-adrenergic blocking agent

As a result, shorter acting alpha-adrenergic blocking agents have been recommended.

The main focus for research should be the role of alpha-adrenergic blocking agents, and their administration shortly after the onset of the CNS event, to determine whether they could prevent the formation of NPE.

The patient was not treated with alpha-adrenergic blocking agents, because they must be administered shortly after the CNS event has taken place.

There is a possible role for alpha-adrenergic blocking agents, provided that they are administered immediately after the occurrence of the CNS event to counteract the massive sympathetic discharge.